Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ERLOTINIB | 150MG | TABLET | Resolved | 2019-02-06 | 2019-11-21 | 74878 |
| APO-ERLOTINIB | 25MG | TABLET | Resolved | 2019-02-06 | 2019-11-21 | 74881 |
| APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-03-05 | 2019-03-09 | 77878 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-03-05 | 2019-03-09 | 77881 |
| APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-03-06 | 2019-03-09 | 77971 |
| APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-06-26 | 2020-01-20 | 87517 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-08-28 | 2020-02-19 | 92522 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-04-13 | 2020-05-19 | 111909 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-01-08 | 2021-01-26 | 131157 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-02-26 | 2021-03-08 | 134814 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-04-09 | 2021-05-17 | 137244 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2024-08-29 | 2024-10-25 | 236243 |
| APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2024-08-29 | 2024-09-20 | 236258 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2024-02-09 | 2024-03-01 | 219144 |
| APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2017-03-13 | 2017-03-29 | 742 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2017-03-13 | 2017-04-20 | 745 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2018-11-30 | 2019-02-08 | 68218 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2018-12-12 | 2019-02-26 | 69299 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-04-30 | 2021-05-17 | 138343 |
| APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-11-22 | 2022-02-15 | 149708 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
| APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-07-13 | 60758 |
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |
| APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60766 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60769 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60772 |
| APO-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60775 |
| APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2019-02-05 | 60778 |
| APO-SALVENT TABLETS - 2MG | 2MG | TABLET | Discontinued | 2018-02-23 | 2018-12-28 | 40854 |
| APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40847 |
| APO-SERTRALINE | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-09-15 | 60781 |
| APO-SILDENAFIL | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60784 |
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-SIMVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60790 |
| APO-SIMVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-11-19 | 60793 |
| APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
| APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |